OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 76 filers reported holding OCULAR THERAPEUTIX INC in Q2 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $177,000 | -27.2% | 28,587 | +9.1% | 0.00% | -50.0% |
| Q2 2017 | $243,000 | +5.7% | 26,201 | +5.9% | 0.00% | 0.0% |
| Q1 2017 | $230,000 | +15.0% | 24,739 | +3.5% | 0.00% | +100.0% |
| Q4 2016 | $200,000 | -7.8% | 23,909 | -24.4% | 0.00% | -50.0% |
| Q3 2016 | $217,000 | +26.2% | 31,643 | -9.1% | 0.00% | 0.0% |
| Q2 2016 | $172,000 | -36.1% | 34,792 | +25.1% | 0.00% | -33.3% |
| Q1 2016 | $269,000 | -11.8% | 27,816 | -14.6% | 0.00% | 0.0% |
| Q4 2015 | $305,000 | -94.4% | 32,583 | -15.7% | 0.00% | -50.0% |
| Q3 2015 | $5,436,000 | +955.5% | 38,665 | +57.9% | 0.01% | +50.0% |
| Q2 2015 | $515,000 | – | 24,483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |